• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Proveris Scientific
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

News

MAP announces Levadex trial results

A PD study has shown no statistically significant difference in pulmonary artery pressure effects of Levadex inhaled dihydroergotamine (DHE) compared to placebo, according to MAP Pharmaceutical. The inhaled formulation had a smaller effect on pulmonary artery pressure than IV DHE. MAP has said that it intends to submit an NDA for Levadex for the treatment of … [Read more...] about MAP announces Levadex trial results

Prosonix launches co-crystal services

Prosonix has announced the availability of a new co-crystal development and processing service using its ultrasound technology for the manufacture of co-crystal APIs for inhalation products. According to the company, the process creates co-crystals with improved solubility and particle size distribution control. Read the company's press release. … [Read more...] about Prosonix launches co-crystal services

Marketing authorization for PecFent nasal spray

According to Archimedes Pharma, the European Commission has granted marketing authorization for the company's PecFent fentanyl nasal spray for the treatment of breakthrough pain in adult cancer patients. Archimedes submitted an NDA for the product to the US FDA in 2009 and is waiting for US approval. Read the company's press release. … [Read more...] about Marketing authorization for PecFent nasal spray

Quintiles to support Bronchitol commercialization

Quintiles has announced that it will provide commercialization services to Pharmaxis for the launch of Pharmaxis's Bronchitol mannitol DPI for the treatment of Cystic Fibrosis. Bronchitol has received orphan drug status in both Europe and the US, and Pharmaxis has filed an MAA with the EMA. Read the company's press release. … [Read more...] about Quintiles to support Bronchitol commercialization

Cypress Bioscience licenses two OINDPs

Cypress Bioscience of San Diego, California has aquired worldwide licensing rights for Alexza Pharmaceutical's Staccato Nicotine inhaler for smoking cessation. Alexza will receive $5 million up front, with another $1 million due upon meeting preclinical and clinical milestones. Read the company's press release. Cypress also announced that it purchased … [Read more...] about Cypress Bioscience licenses two OINDPs

Abbott terminates Flutiform agreement with Skye

Skye Pharma says that it understands why Abbot has decided to return US marketing rights for the Flutiform formoterol fluticasate MDI given the issues raised by the US FDA concerning approval of the drug. According to Skye, it will look for a new licensee if the company can find a way to move forward with the NDA. Read the company's press release. … [Read more...] about Abbott terminates Flutiform agreement with Skye

Archimedes to open US headquarters in New Jersey

Archimedes Pharma, which has submitted an NDA for its lead product, PecFent fentanyl nasal spray, announced that it anticipates creating as many as 75 new jobs at its new US headquarters in Bedminster, NJ. The company's main headquarters are in Reading, UK. Read the company's press release. … [Read more...] about Archimedes to open US headquarters in New Jersey

MannKind announces $110 million stock agreement

MannKind Corporation, which is waiting for FDA approval of its Afrezza inhaled insulin, announced that it hopes to raise up to $110 million by lending 9 million shares of its stock to Bank of America. Merrill Lynch will then sell the borrowed shares, shorting the stock, and will use the proceeds in conjunction with a private offering of MannKind Senior Convertible … [Read more...] about MannKind announces $110 million stock agreement

Cannabis Science and Smokefree Innotec sign development agreement

Cannabis Science and Smokefree Innotec will co-develop pharmaceutical cannabis products for inhalation. Smokefree Innotec, which manufactures electronic cigarettes, will develop the devices, with Cannabis Science developing the formulations. Read the company's press release … [Read more...] about Cannabis Science and Smokefree Innotec sign development agreement

Alexza hires new VP, Quality

Alexza has hired Darl Moreland as its new Vice President, Quality. Moreland was previously VP, Quality Assurance and Compliance and Chief Compliance officer for Mentor Worldwide. At Alexza, he will be responsible for quality assurance, quality control, and quality system regulatory compliance. Read the company's press release. … [Read more...] about Alexza hires new VP, Quality

  • « Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 414
  • Page 415
  • Page 416
  • Page 417
  • Next Page »

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Solstice Air banner
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews